MHLW Doubles Budget For Generic Drug Use Promotion Measures
This article was originally published in PharmAsia News
Executive Summary
Japan's Ministry of Health, Labor and Welfare doubled its budget request for promotion measures of generic drug use in fiscal year 2009. The budge requested ¥91 million compared to ¥45 million appropriated in FY2008. The increased amount will be used to establish programs at the local level to raise public awareness and further generic drug use, which is key to the government's goal of keeping social security increases within ¥210 billion annually. In addition, the budget also requested ¥146 million for information gathering in generic drug's quality, ¥45 million for quality assurance and ¥7 million to conduct market research of generic drug use in Europe and the U.S. (Click here for more - Japanese language
You may also be interested in...
Japan Seeks ¥20 Billion In Spending Cuts With Generic Utilization
TOKYO - Japan Prime Minister Taro Aso's government Dec. 16 unveiled a draft proposal to finance natural social security expenditures growth in fiscal 2009 partly with ¥20 billion in spending cuts for prescription drugs by encouraging the use of generic drugs
Japan’s Slow Generic Use Caused By Physician Attitudes, Survey Says
TOKYO - Generic drugs' penetration into the Japanese pharmaceutical market has been languishing below 20 percent, and as many as 83 percent of consumers said their physicians have not recommended they switch from brand drugs, according to a survey released by research firm Ishare, Oct. 20
As Casgevy, Lyfgenia Launches Proceed, CRISPR And bluebird bio CEOs Reassure
The CEOs of bluebird bio and CRISPR Therapeutics hope to inspire investor confidence that their gene-based therapies for sickle cell disease and beta thalassemia will be widely reimbursed in the US and EU.